MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,389,574 | +289.5% | 328,784 | +218.9% | 0.03% | +300.0% |
| Q2 2023 | $2,667,456 | +165.9% | 103,110 | +115.9% | 0.01% | +133.3% |
| Q3 2022 | $1,003,000 | -57.5% | 47,748 | -60.6% | 0.00% | -62.5% |
| Q2 2022 | $2,360,000 | -45.3% | 121,292 | -38.1% | 0.01% | -38.5% |
| Q1 2022 | $4,313,000 | +59.1% | 195,879 | +15.2% | 0.01% | +116.7% |
| Q4 2021 | $2,711,000 | -12.4% | 169,977 | +9.5% | 0.01% | -14.3% |
| Q3 2021 | $3,093,000 | +90.5% | 155,275 | +65.3% | 0.01% | +75.0% |
| Q2 2021 | $1,624,000 | -14.7% | 93,915 | -2.2% | 0.00% | -20.0% |
| Q1 2021 | $1,903,000 | +626.3% | 96,020 | +540.1% | 0.01% | +400.0% |
| Q4 2020 | $262,000 | -74.2% | 15,000 | -71.6% | 0.00% | -75.0% |
| Q3 2020 | $1,017,000 | +16.6% | 52,783 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $872,000 | – | 44,793 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |